Raju Prasad

Role: Chief Financial Officer at CRISPR Therapeutics
Location: Boston, MA, US
LinkedIn followers: 500 followers

Finance & AccountingView LinkedIn profile

About Raju Prasad

Life sciences Ph.D. with work experience in finance, biotech, healthcare, and government.…

Experience

Chief Financial Officer
CRISPR Therapeutics
Mar 2023 — Present

Education

The University of North Carolina at Chapel Hill
Doctor of Philosophy (Ph.D.), Public Health
2009 — 2013
Rutgers University
Bachelor of Arts (B.A.), Cell Biology, Philosophy
2001 — 2005
University of Delaware
Master of Science (M.S.), Physiology
2006 — 2008

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@crisprtx.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

CRISPR Therapeutics

Biotechnology Research · 343 employees · Founded 2013 · Boston, Massachusetts, United States

Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.

crisprtx.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Raju Prasad

Experience

Chief Financial Officer

Education

The University of North Carolina at Chapel Hill

Rutgers University

University of Delaware

Find verified contacts for anyone on LinkedIn